Inhibition of NF-κB activity enhances TRAIL mediated apoptosis in breast cancer cell lines

Breast Cancer Research and Treatment

Volumn 64, Issue 2, 2000, Pages 211-219

  Keane, M M ^a   Rubinstein, Y ^a   Cuello, M ^a   Ettenberg, S A ^b   Banerjee, P ^a   Nau, M M ^a   Lipkowitz, S ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Apoptosis; Breast cancer; Caspases; NF B; TRAIL

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; APOPTOSIS REGULATORY PROTEIN; MEMBRANE PROTEIN; TNFSF10 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; BREAST TUMOR; CELL CULTURE; DRUG EFFECT; DRUG INTERACTION; FEMALE; PATHOLOGY;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; DRUG INTERACTIONS; FEMALE; HUMANS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034353454     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006458407515     Document Type: Article

References (42)

1. Apoptosis control by death and decoy receptors
2. Death receptors: Signaling and modulation
3. The TNF receptor super-family of cellular and viral proteins: Activation, costimulation, and death
4. Lethal effect of the anti-Fas antibody in mice
5. TRAIL: A molecule with multiple receptors and control mechanisms
6. Identification and characterization of a new member of the TNF family that induces apoptosis
7. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
8. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
9. The receptor for the cytotoxic ligand TRAIL
10. TRAIL/Apo-2-ligand-induced apoptosis in human T cells
11. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
12. Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity
13. Tumor-necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT- 11
14. Safety and antitumor activity of recombinant soluble Apo2 ligand
15. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
16. Activity of TNF-related apoptosis-inducing ligand (TRAIL) in haematological malignancies
17. Selectivity of TRAIL-mediated apoptosis of cancer cells and synergy with drugs: The trail to non-toxic cancer therapeutics
18. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma
19. TRAIL death pathway expression and induction in thyroid follicular cells
20. Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells
21. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
22. The novel receptor TRAIL-R4 induces NF-KappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
23. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway
24. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB
25. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death
26. NF-kappa B: Ten years after
27. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras
28. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation
29. Suppression of TNF-alpha-induced apoptosis by NF-kappaB
30. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10
31. A simple assay for examining the effect of transiently expressed genes on programmed cell death
32. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation
33. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
34. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis
35. The cytotoxic cell protease granzyme B initiates apoptosis in a cell-free system by proteolytic processing and activation of the ICE/CED-3 family protease, CPP32, via a novel two-step mechanism
36. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9- dependent manner
37. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth
38. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer
39. Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells
40. TRAIL induces apoptosis and activation of NFkappaB
41. Functional analysis of TRAIL receptors using monoclonal antibodies
42. Inhibition of death receptor signals by cellular FLIP